Jazz Pharmaceuticals
JAZZ
JAZZ
503 hedge funds and large institutions have $10.1B invested in Jazz Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 213 increasing their positions, 129 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.36% less ownership
Funds ownership: 94.53% → 94.16% (-0.36%)
0% less call options, than puts
Call options by funds: $167M | Put options by funds: $167M
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
503
Holding in Top 10
8
Calls
$167M
Puts
$167M
Top Buyers
| 1 | +$230M | |
| 2 | +$175M | |
| 3 | +$114M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$78.8M |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$46.7M |
Top Sellers
| 1 | -$73.2M | |
| 2 | -$68.2M | |
| 3 | -$61.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$52M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$43.5M |